FDA Alerts

Diabetes Q&A
Diabetes Q&A
FDA Approves Rapid-Acting Inhaled Insulin Powder
06/30/2014
The FDA has approved Afrezza, an inhaled insulin device for use in patients with type 1 and type 2 diabetes.
06/30/2014
Allergy
Allergy
FDA Warns of Life-Threatening Allergic Reactions to OTC Acne Products
06/26/2014
Rare, but serious allergic reactions, including swelling of the face, lips, tongue, eyes, and dyspnea, have been reported.
06/26/2014
all
all
FDA warns of serious allergic reactions with acne products
06/26/2014
...
06/26/2014
skin infection
skin infection
FDA Approves Sivextro To Treat Skin Infections
06/23/2014
The FDA has approved a second antibacterial drug to treat acute bacterial skin and skin structure infections.
06/23/2014
FDA Alerts
FDA Alerts
Genetics startup 23andMe takes step on path to FDA approval
06/23/2014
By...
06/23/2014
Endocrine system
Endocrine system
FDA Requires New Warning on Testosterone Products
06/21/2014
The FDA has called for a new warning label for venous blood clots to be included on all testosterone products.
06/21/2014
Endocrine system
Endocrine system
FDA: First Nasal Spray Approved to Treat Hypogonadism
06/17/2014
The FDA has approved the first testosterone nasal gel for the treatment of patients with hypogonadism.
06/17/2014
FDA Alerts
FDA Alerts
FDA panel advises against large opioid-constipation drug safety trials
06/13/2014
By Reuters Staff
06/13/2014
opioid
opioid
Long-Acting Hemophilia Drug and Buccal Therapy for Opioid Dependence Get FDA Nod
06/09/2014
Two important drugs–a long-lasting Hemophilia treatment and the first buccal film therapy for opioid dependance–were recently approved by the FDA.
06/09/2014
FDA Alerts
FDA Alerts
FDA gives muscular dystrophy drug new path towards approval
06/04/2014
By Reuters Staff
06/04/2014